Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020

OMICS. 2020 Feb;24(2):60-61. doi: 10.1089/omi.2019.0205. Epub 2020 Jan 9.

Authors

Ramy K Aziz^{1

2}, Mariam R Rizkallah³, Rama Saad⁴, Marwa T ElRakaiby^{1

2}

Affiliations

¹ Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
² Center for Genome and Microbiome Research, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
³ Department of Biometry and Data Management, Leibniz Institute for Prevention Research and Epidemiology, BIPS, Bremen, Germany.
⁴ Department of Pathology, College of Medicine, University of Illinois, Chicago, Illinois.

PMID: 31916888
DOI: 10.1089/omi.2019.0205

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Infective Agents / pharmacology*
Genetic Engineering
High-Throughput Screening Assays
Humans
Microbiota / drug effects*
Precision Medicine
Translational Research, Biomedical* / methods

Substances

Anti-Infective Agents